Ronald Hunt is Director & 10% Owner at Harpoon Therapeutics, Inc. (HARP). They have made 8 open-market trades across 6 companies since 2012, most recently 2024-08-06.
CIK 0001247851
6 open-market purchases totalling $29.7M since 2012, against 2 sales. Across 5 scored buys the stock is down 15.4% at ninety days, and 19.3 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 20% |
| Avg Move | -10.0% | -14.0% | -15.4% |
| Alpha | -9.9% | -15.1% | -19.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLYB | BUY | 2021-08-02 | 2021-08-04 | $13.00 | $2.0M | -22.6% | -29.8% | -5.4% |
| HARP | BUY | 2021-01-11 | 2021-08-12 | $17.00 | $4.0M | -3.6% | -8.1% | -29.7% |
| HARP | BUY | 2019-02-12 | 2019-02-14 | $14.00 | $6.0M | +5.1% | -14.7% | -29.0% |
| ITRM | BUY | 2018-05-30 | 2018-05-31 | $13.00 | $8.6M | +1.7% | -17.9% | -13.3% |
| MEIP | SELL | 2014-12-08 | 2014-12-10 | $6.01 | $476K | -14.3% | +3.7% | +3.7% |
| RLYP | BUY | 2013-11-20 | 2013-11-20 | $11.00 | $2.0M | -30.6% | +0.6% | +0.6% |
| MEIP | SELL | 2013-05-06 | 2013-05-08 | $8.58 | $1.7M | -14.3% | +3.7% | +3.7% |
| DRTX | BUY | 2012-07-24 | 2012-07-26 | $9.00 | $7.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $100.0M |
Shares reported on the most recent Form 4, priced at the 2024-08-12 close. 1 holding could not be priced and is excluded from the total.